Drug GMP Report: Subscribe Now!
Drug GMP Report
You’ve probably wished you had access to the inner workings of the FDA. A trusted friend there with insights into the interpretation and enforcement of cGMPs. You’d turn to this person often for information to help you stay in compliance and maintain your competitive edge.
Turn to us today! Drug GMP Report is prepared with you in mind. Drug GMP Report has the insights and latest information you must know to ensure your processes, procedures and controls are compliant.
Each issue is packed with:
- Analysis and in-depth interpretation of GMPs
- Details of new FDA inspection hot spots
- Developments in certification procedures
- Insights on quality metrics and electronic data requirements
- Evolving trends in drug GMP enforcement
- Updates on EU pharmacovigilence initiatives and data integrity
- News on harmonization efforts, track and trace and international regulations
Know exactly which proactive adjustments to make as well as be equipped enough to avoid slowdowns. Get the newsletter today to join many other manufacturers who received this support in the past 20 years. Don’t miss out.
Bonus! You’ll also receive critical documents within each issue, such as draft or final guidances, 483s and warning letters, proposed rules, full text of proposed legislation and more.
Subscribe now to start your single-user one-year subscription (12 issues) to Drug GMP Report for only $1,045. You’ll immediately gain access to the latest issue as well as a searchable database of over 20 years of past issues.
Also available: Take advantage of our multi-user and site licenses of Drug GMP Report, so you’ll have the most-informed workforce! Contact Bailey Sterrett, Director, BD at firstname.lastname@example.org or +1 703.538.7637 to receive a custom quote.
Call toll free 888.838.5578 or 703.538.7600. You can also click here to subscribe online today!
We’re confident the value Drug GMP Report provides you will pay for itself many times over. If you disagree, there’s our 100% Money-Back Guarantee.